Clinical Trial Update: Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency [Phase 2]

View source ↗

Summary

Phase 2 study of AOBO-001 for overactive bladder with urge urinary incontinence and frequency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• AOBO-001

Snippet

Sponsor: American Oriental Bioengineering, Inc. | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED